Analytical Data
-
Gene name
FCY1
- Application
-
Alternative Names
Cytosine aminohydrolase
-
Species
Saccharomyces cerevisiae
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q12178
-
Expression Region
1-158aa
-
Molecular Weight
25.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FCY1, or "Folin-Ciocalteu Y1," is a protein of increasing interest in biochemical research due to its pivotal role in the folate metabolism pathway. Folates are essential vitamins that play a critical role in DNA synthesis, repair, and methylation, making them vital for cell growth and division. Dysregulation of folate metabolism has been linked to various health issues, including neural tube defects, cardiovascular diseases, and certain types of cancers. The FCY1 protein is involved in the transport and conversion of folate compounds, making it integral to maintaining cellular folate levels. Understanding the structure and function of FCY1 through recombinant protein studies can provide insights into its mechanisms and interactions, as well as potential implications for therapeutic approaches. Researchers are particularly interested in FCY1 for its potential as a target for drug development, especially in cancer treatments where folate metabolism is often altered. By elucidating the biochemical properties and pathways associated with FCY1, scientists aim to enhance the understanding of folate-related processes in health and disease, paving the way for innovative strategies in disease prevention and treatment. This research underscores the importance of FCY1 in metabolic pathways and its potential role in therapeutic interventions, emphasizing the need for further exploration in the context of both basic and applied biomedical sciences.
